Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
3
currently held
Exits tracked
1
hand-checked
Sectors covered
1
across the portfolio
Countries covered
4
from every market
4 companies matching
| Company | Sector | Geo | Investor | Entry | Status | |
|---|---|---|---|---|---|---|
DIESSE MED II | Diagnostics |  Italy | ARCHIMED | 2019 | Exited 2025 | |
ZYTOMICS MED Platform I | Diagnostics |  Germany | ARCHIMED | 2020 | Active | |
ARK Diagnostics MED Platform II | Diagnostics |  United States | ARCHIMED | 2025 | Active | |
BioVendor Group MED III | Diagnostics | Czech Republic | ARCHIMED | 2025 | Active |
DIESSE
MED II
ItalySector
Diagnostics
InvestorARCHIMED
Entry
2019
Hold
6yr
Exit
2025
ZYTOMICS
MED Platform I
GermanySector
Diagnostics
InvestorARCHIMED
Entry
2020
Hold
6yr
ARK Diagnostics
MED Platform II
United StatesSector
Diagnostics
InvestorARCHIMED
Entry
2025
Hold
1yr
BioVendor Group
MED III
Czech Republic
Sector
Diagnostics
InvestorARCHIMED
Entry
2025
Hold
1yr